Guidance

Subcategories:Clinical Criteria/Guidelines Ethics Legal Updates Legislation & Advocacy Meeting Reports Research Rheum

Biosimilar Drugs Face Challenges to Reach the U.S. Market

Kathleen Louden | March 8, 2012

To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.

A Journey Begins with the First Step

David I. Daikh, MD, PhD | March 8, 2012

The ACR Research and Education Foundation (REF) has launched the Action Alliance network, a program that calls on rheumatologists, investigators, and health professionals to join the REF in asking patients and families to be a part of the conversation. The Action Alliance consists of two programs working together: From the Field Speakers Bureau and Patients and Families for Progress.

Magnify Rheumatology’s Legislative Impact this Month

Staff | March 8, 2012

Members of the ACR’s Executive, Government Affairs, and RheumPAC Committees, along with the Affiliate Society Council, attended 75 meetings with legislators and their staff. These meetings are critical to advancing awareness of rheumatology and the issues affecting your profession and patients.

ACR’s Advocacy Toolkit

Staff | March 8, 2012

Ways to contact your member of Congress; tips for communicating with your member of Congress; ways to get patients involved; and donloadable briefs, posters, and brochures.

ACR Partners with Patient Organizations

Staff | March 8, 2012

The ACR met with representatives from 14 patient advocacy organizations in Washington, D.C., to discuss mutual advocacy and legislative objectives.

ARHP Members Earn Leadership Position, Award

Staff | March 8, 2012

Kamala Nola, PharmD, MS, was inducted as the 2011-2012 president-elect of the Tennessee Pharmacists Association; Danuta Bujak, PhD, FNP, an ARHP member, was honored as the recipient of the 2011 Yale School of Nursing Distinguished Alumna Award.

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres | March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Link between Autoimmunity and Environmental Exposure Needs Further Research

Vanessa Caceres | March 8, 2012

Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

How to Retire from Your Medical Practice

Steven M. Harris, Esq. | March 8, 2012

If you are a physician nearing retirement, it is important that you plan, discuss, and make contractual agreements that will allow you to accomplish your goals and changing needs.

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Carrie Printz | February 28, 2012

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).